13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000950123-23-008070
Total Value
$2.24B
Positions
20
Other Managers
3
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 12,882,819 | $1.57B | 69.85% |
| 2 | Sana Biotechnology Inc | SANA | 21,166,448 | $126.2M | 5.63% |
| 3 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $124.5M | 5.56% |
| 4 | Denali Therapeutics Inc | DNLI | 2,619,968 | $77.3M | 3.45% |
| 5 | Sana Biotechnology Inc | SANA | 12,123,570 | $72.3M | 3.22% |
| 6 | Seres Therapeutics Inc | MCRB | 14,664,169 | $70.2M | 3.13% |
| 7 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $65.7M | 2.93% |
| 8 | Seres Therapeutics Inc | MCRB | 8,452,876 | $40.5M | 1.81% |
| 9 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $39.1M | 1.75% |
| 10 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $23.5M | 1.05% |
| 11 | Sigilon Therapeutics Inc | 82657L206 | 683,760 | $15.4M | 0.69% |
| 12 | Evelo Biosciences Inc | EVEX-WT | 1,502,970 | $4.9M | 0.22% |
| 13 | Axcella Health Inc | 05454B105 | 18,142,125 | $4.0M | 0.18% |
| 14 | Sigilon Therapeutics Inc | 82657L206 | 113,960 | $2.6M | 0.11% |
| 15 | Axcella Health Inc | 05454B105 | 11,109,420 | $2.4M | 0.11% |
| 16 | Syros Pharmaceuticals Inc | 87184Q206 | 700,000 | $2.2M | 0.10% |
| 17 | Evelo Biosciences Inc | EVEX-WT | 510,265 | $1.7M | 0.07% |
| 18 | Evelo Biosciences Inc | EVEX-WT | 508,134 | $1.7M | 0.07% |
| 19 | Syros Pharmaceuticals Inc | 87184Q206 | 293,848 | $925,622 | 0.04% |
| 20 | Moderna Inc | MRNA | 3,924 | $476,766 | 0.02% |